Friday Five: Verges neuro drug-to-data pivot on June 19, 2026 AI drug discovery digital dermatology drug-to-data pivot Friday Merck Neurology speciality protein design AI Verge Labs +
Roche Launches Up to $2.3B Blood‑Cancer Bet Around Nurix’s BTK Degrader Bexobrutideg on June 08, 2026 bexobrutideg BTK BTK degrader Chronic Lymphocytic Leukemia CLL Hematologic Neoplasms Immunology malignant haematology Neurology speciality Nurix Roche (company) +
28bio Launches CNS-3D Myelinated Organoids to Predict Therapeutic Efficacy on May 14, 2026 brain organoids CNS-3D demyelination Drug Evaluation, Preclinical human-relevant models myelin repair Myelin Sheath Neurodegenerative Disorders Neurology speciality Nexon platform Organoids remyelination +
Angelini Fortifies Neurology Portfolio with $4.1B Buyout of Catalyst on May 08, 2026 acquisition Angelini Pharma Catalyst Pharmaceuticals Infrequent Market Neurology speciality US +
Biogen Pursues Early-Stage Assets to Build Next Generation Growth Pipeline on April 30, 2026 Apellis acquisition assets Biogen early-stage growth strategy Immunology M&A Neurology speciality pipeline +
Sanofi Injects $625M Into Biotech Investment Arm to Accelerate Innovation on September 24, 2025 Cash cell/gene therapy digital health expansion Immunology Infrequent Infusion procedures Investments Neurology speciality portfolio sanofi Sanofi Ventures venture capital +
XtalPi and DoveTree Announce Landmark $6 Billion AI-Powered Drug Discovery Collaboration on August 07, 2025 Artificial Intelligence Dosage Forms DoveTree Medicines Drug Discovery Gregory Verdine Immunology Neoplasms Neurology speciality Robotics XtalPi +
Illumina and Tempus look beyond cancer in new AI-driven genomics deal on April 16, 2025 Artificial Intelligence Cardiology discipline Genetic Profile Genomics High-Throughput Nucleotide Sequencing Illumina Immunology Malignant Neoplasms Neurology speciality Partnership +